
Gustavo R. Sarria
@sarriagustavo
Radiation Oncologist & Clinical Investigator 🇵🇪 🇩🇪 @UniklinikBonn. Global health advocate @Cancerrayos
ID: 380474006
https://orcid.org/0000-0002-5929-7270 26-09-2011 18:18:16
106 Tweet
325 Followers
645 Following






New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance of recurrence, which is high. With this nomogram, those with other risk levels can be identified Matthew Culbert, MD 1/2



👏🏽👏🏽👏🏽Shankar Siva on presentation of SAFRON II final results. Single fraction now standard of care for suitable pulmonary oligometastases, esp in COVID era? Equivalent cancer outcomes, SF 30% ⬇️ costs. TROG Cancer Research ESTRO #ESTRO2021




Thank you Anthony Zietman, Professor Pat Price and Sandra Turner for sharing your advocacy success stories at the GCR meeting. Watch in full bit.ly/3FQshSM. Let us know your thoughts and join us for our next meeting!

Nebenwirkungen, die unerwartet & erst lange nach der Impfung auftreten, sind bisher bei keiner Impfung beobachtet worden & sind auch bei den #COVID19-Impfstoffen nicht zu erwarten. Siehe FAQ: rki.de/SharedDocs/FAQ… Weitere Informationen zur Sicherheit bei Paul-Ehrlich-Institut #ÄrmelHoch



Calling all #ClinOnc #Radonc Non-UK welcome Dont miss this opportunity with #WhereisHoskin! Great Clinical PhD funded by Cancer Research UK Involves #MRLinac #biomarkers #WhereisvanHerk Contact us to find out more Closing date 24/11 Alan McWilliam ESTRO ASTRO crukcentre.manchester.ac.uk/opportunities/…



